PRISM BioLab Co.,LTD (TYO:206A)
Japan · Delayed Price · Currency is JPY 160.00
-3.00 (-1.84%)
Aug 6, 2026, 1:32 PM JST
PRISM BioLab Co.,LTD Revenue
PRISM BioLab Co.,LTD had revenue of 120.08M JPY in the quarter ending March 31, 2026, with 28.19% growth. This brings the company's revenue in the last twelve months to 711.65M, up 74.08% year-over-year. In the fiscal year ending September 30, 2025, PRISM BioLab Co.,LTD had annual revenue of 677.33M with 121.62% growth.
Revenue (ttm)
711.65M
Revenue Growth
+74.08%
P/S Ratio
8.47
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.03B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 677.33M | 371.71M | 121.62% |
| Sep 30, 2024 | 305.62M | 192.69M | 170.64% |
| Sep 30, 2023 | 112.93M | -441.07M | -79.62% |
| Sep 30, 2022 | 554.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.